(Q35030815)

5 August 2017

1 reference

title

Impact and modulation of nasal obstruction (English)

1 reference

5 August 2017

F Horak

1

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

57 Suppl 75

1 reference

5 August 2017

page(s)

25-28

1 reference

Adrenoceptors in the Control of Human Nasal Mucosal Blood Flow

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

Therapeutic points of intervention and clinical implications: role of desloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

Desloratadine: A new, nonsedating, oral antihistamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

Introduction to nasal and pulmonary allergy cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

7 January 2021

Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

7 January 2021

Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

7 January 2021

Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.57.S75.5.X

7 January 2021

10.1034/J.1398-9995.57.S75.5.X

Identifiers

DOI

1 reference

5 August 2017

1 reference